Showing results (141-150 of 249) with videos related to
Sort By:
Pageof 25
International Journal of Oncology|June 11, 2009
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancerRichard E Francis, Stephen S Myatt, Janna Krol, et al.Scientific Reports|November 29, 2017
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathwayChunlan Xu, Sally Ghali, Jiani Wang, et al.Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.Inflammatory Bowel Diseases|November 22, 2025
Differences in Anti-αvβ6 Integrin Antibody Expression between U.S. and Japanese Cohorts in Inflammatory Bowel DiseaseYoichi Kakuta, Dalin Li, Philip Debbas, et al.Science Translational Medicine|January 3, 2024
NAD+ precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunctionAtika Malique, Shengxiang Sun, Kanta Chandwe, et al.Heliyon|January 29, 2024
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's DiseaseGeorge B McDonald, Ole J B Landsverk, Dermot P B McGovern, et al.The New England Journal of Medicine|September 25, 2024
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative ColitisBruce E Sands, Brian G Feagan, Laurent Peyrin-Biroulet, et al.Journal of Crohn'S & Colitis|October 26, 2021
A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease RecurrenceMargaret Walshe, Shadi Nayeri, Jiayi Ji, et al.Lancet (London, England)|May 25, 2005
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's diseaseDavid A van Heel, Subrata Ghosh, Matt Butler, et al.Inflammatory Bowel Diseases|December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's diseaseAndrew Ippoliti, Shane Devlin, Ling Mei, et al.Pageof 25